A conversion of oral cannabidiol to delta9-tetrahydrocannabinol seems not to occur in humans (2017)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.1089/can.2017.0009
- Subjects: CANABINOIDES; INGESTÃO; METABOLISMO
- Keywords: CANNABIDIOL; DELTA9-TETRAHYDROCANNABINOL; ACID-CATALYZED CYCLIZATION; DEGRADATION; ISOMERIZATION GASTRIC FLUID
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: New Rochelle
- Date published: 2017
- Source:
- Título: Cannabis and Cannabinoid Research
- ISSN: 2378-8763
- Volume/Número/Paginação/Ano: v. 2, n. 1, p. 81-86, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
NAHLER, Gerhard et al. A conversion of oral cannabidiol to delta9-tetrahydrocannabinol seems not to occur in humans. Cannabis and Cannabinoid Research, v. 2, n. 1, p. 81-86, 2017Tradução . . Disponível em: https://doi.org/10.1089/can.2017.0009. Acesso em: 14 fev. 2026. -
APA
Nahler, G., Franjo Grotenhermen,, Zuardi, A. W., & Crippa, J. A. de S. (2017). A conversion of oral cannabidiol to delta9-tetrahydrocannabinol seems not to occur in humans. Cannabis and Cannabinoid Research, 2( 1), 81-86. doi:10.1089/can.2017.0009 -
NLM
Nahler G, Franjo Grotenhermen, Zuardi AW, Crippa JA de S. A conversion of oral cannabidiol to delta9-tetrahydrocannabinol seems not to occur in humans [Internet]. Cannabis and Cannabinoid Research. 2017 ; 2( 1): 81-86.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1089/can.2017.0009 -
Vancouver
Nahler G, Franjo Grotenhermen, Zuardi AW, Crippa JA de S. A conversion of oral cannabidiol to delta9-tetrahydrocannabinol seems not to occur in humans [Internet]. Cannabis and Cannabinoid Research. 2017 ; 2( 1): 81-86.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1089/can.2017.0009 - Induction of psychosis by Δ9- Tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience precessing
- Cannabis affects people differently: inter-subject variation in the psychotogenic effects of ''delta' POT.9'-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers
- Cannabidiol is a potential therapeutic for the affective-motivational dimension of incision pain in rats
- Uso de maconha e ansiedade
- Distinct effects of 'delta'9-Tetrahydrocannabinol and cannabidiol on neural activation during emotional processing
- Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers
- Opposite effects of 'delta'-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology
- Modulation of effective connectivity during emotional processing by ''DELTA' POT.9'-tetrahydrocannabinol and cannabidiol
- Duloxetine in the treatment of panic disorder
- Antidepressant-like and anxiolytic-like effects of Cannabidiol: a chemical compound of Cannabis sativa
Informações sobre o DOI: 10.1089/can.2017.0009 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
